Eli Lilly
LLY
4,673 hedge funds and large institutions have $949B invested in Eli Lilly in 2026 Q2 according to their latest regulatory filings, with 422 funds opening new positions, 2,228 increasing their positions, 1,495 reducing their positions, and 108 closing their positions.
291% more first-time investments, than exits
New positions opened: 422 | Existing positions closed: 108
92% more capital inflows, than outflows
Capital inflows: $45.5B | Capital outflows: $23.7B
49% more repeat investments, than reductions
Existing positions increased: 2,228 | Existing positions reduced: 1,495
25% more funds holding in top 10
Funds holding in top 10: 382 → 478 (+96)
24% more call options, than puts
Call options by funds: $23.8B | Put options by funds: $19.2B
6% more funds holding
Funds holding: 4,408 → 4,673 (+265)
2.02% more ownership
Funds ownership: 82.11% → 84.13% (+2%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$4.55B |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$2.17B |
| 3 |
SG Americas Securities
New York
|
+$1.36B |
| 4 |
Goldman Sachs
New York
|
+$1.34B |
| 5 |
BlackRock
New York
|
+$1.18B |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital Research Global Investors
Los Angeles,
California
|
-$3.84B |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
-$2.48B |
| 3 |
Lilly Endowment
Indiananapolis,
Indiana
|
-$1.55B |
| 4 |
JP Morgan Chase
New York
|
-$1.12B |
| 5 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$1.07B |
LLY Hedge Fund Activity: Q2 2026 in Review
4,673 of the 8,401 institutional investors tracked by Wall St. Rank reported a position in Eli Lilly (LLY) for Q2 2026, worth a combined $949B — up 33% from $713B a quarter earlier.
Buyers outnumbered sellers: 422 funds opened new LLY positions and 108 closed out — a net gain of 314 holders — while 2,228 added to existing stakes and 1,495 trimmed.
The largest buyer was Royal Bank of Canada, adding an estimated $4.55B. The largest seller was Capital Research Global Investors, cutting an estimated $3.84B.
- 4,673 institutional investors held Eli Lilly (LLY) as of Q2 2026, up from 4,408 in Q1 2026.
- Funds reported $949B of Eli Lilly stock for Q2 2026, up 33% quarter-over-quarter.
- 422 funds opened new Eli Lilly positions in Q2 2026 and 108 closed out, a net change of +314 holders.
- The largest Eli Lilly buyer in Q2 2026 was Royal Bank of Canada, an estimated $4.55B added.
- The largest Eli Lilly seller in Q2 2026 was Capital Research Global Investors, an estimated $3.84B sold.
Based on aggregated 13F filings for Q2 2026.